A Crossover Clinical Trial Investigating the Effects of Geranylgeraniol (GG) Supplementation on Testosterone Levels in Healthy Men and Women Over an 18-week Period

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions

WellnessHealth

Interventions

DIETARY_SUPPLEMENT

Geranylgeraniol 300 mg

300 mg of trans-geranylgeraniol (GG)

DIETARY_SUPPLEMENT

Placebo

300 mg medium chain triglycerides

Trial Locations (1)

Designs for Health, Inc., Palm Coast